Given Imaging keeping tradition, announces $5m Q1 revenue beat Street

Ingestible camera-maker Given Imaging (Nasdaq: GIVN) today announced the top line of its Q1 2002 financials in what has become customary for the company, reporting that sales of the M2A capsule and accompanying equipment amounted to $5 million, beating Wall Street projections.

"Customary" as in the preceding quarter the company also published a revenue announcement when it had complete figures for quarterly sales. This is Given Imaging's third quarter as a public company after going public in October 2001.

If Given does post $5 million in revenues, this would represent a 43% increase over the preceding quarter. In the parallel quarter, Given had no revenue, with sales beginning earlier than planned in Q3 2001.

Robertson Stephens had projected $4 million and Lehman Brothers has projected $4.5 million.